These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34226290)

  • 1. Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):16-24. PubMed ID: 34226290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors and risk of colorectal cancer.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):111-118. PubMed ID: 34210775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study.
    Abrahami D; Pradhan R; Yin H; Yanofsky R; McDonald EG; Bitton A; Azoulay L
    Gut; 2023 Jul; 72(7):1288-1295. PubMed ID: 36717221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study.
    Zeng R; Ma Y; Zhang L; Luo D; Jiang R; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
    Elife; 2024 Jul; 13():. PubMed ID: 39012339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
    Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
    Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study.
    Lin HC; Huang KT; Lin HL; Uang YS; Ho Y; Keller JJ; Wang LH
    PLoS One; 2021; 16(3):e0249050. PubMed ID: 33765029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in Thailand.
    Pannoi T; Promchai C; Apiromruck P; Wongpraphairot S; Dong YH; Yang CC; Pan WC
    PeerJ; 2024; 12():e16892. PubMed ID: 38371380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
    Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
    Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
    Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
    Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
    Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children.
    Noh Y; Jeong HE; Choi A; Choi EY; Pasternak B; Nordeng H; Bliddal M; Man KKC; Wong ICK; Yon DK; Shin JY
    JAMA Pediatr; 2023 Mar; 177(3):267-277. PubMed ID: 36622684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
    Poulsen AH; Christensen S; McLaughlin JK; Thomsen RW; Sørensen HT; Olsen JH; Friis S
    Br J Cancer; 2009 May; 100(9):1503-7. PubMed ID: 19352380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.